Last reviewed · How we verify

NCT05190640

Study to Evaluate the Efficacy of Asystems' Complete Calm Supplementation on Sleep Quality and Duration, Anxiety, and Stress

Completed NA Last updated 1 April 2022
What this trial tests

NA trial testing De-Stress Gummies in Sleep in 35 participants. Completed in 15 March 2022.

Timeline
1 November 2021
Primary endpoint
15 March 2022
15 March 2022

Quick facts

Lead sponsorAsystem, Inc.
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposeother
Enrollment35
Start date1 November 2021
Primary completion15 March 2022
Estimated completion15 March 2022
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Asystem, Inc.

Who can join

Adults 24 to 45, any sex, with Sleep or Stress. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is an open-label observational single-arm clinical trial to study the efficacy of a commercial dietary supplement and its effect on sleep quality, sleep duration, anxiety, mood, and stress.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Sleep

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05190640.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing